Oncomatryx Biopharma, S.l.

Calculating rank

USPTO Granted Patents = 4

EPO Patents = 7

Forward Citations = 8

Loading Chart...

18 inventors (with patents filed for the assignee):

Klaus Pfizenmaier (3 out of 21 patents)

Roland Kontermann (3 out of 25 patents)

Cristina Ferrer (3 out of 3 patents)

4. Myriam Fabre (3 out of 4 patents)

5. Laureano Simon (3 out of 7 patents)

6. Luis Barneo Serra (1 out of 1 patent)

7. Carmen Garcia Pravia (1 out of 1 patent)

8. Marcos Garcia Ocana (1 out of 1 patent)

9. Juan Ramon De Los Toyos Gonzalez (1 out of 1 patent)

10. Jose Fernando Vazquez Villa (1 out of 1 patent)

11. Nelson Fuentes Martinez (1 out of 1 patent)

12. Jokin Del Amo Iribarren (1 out of 1 patent)

13. Laureano Simón Buela (1 out of 9 patents)

14. José Javier Gómez Román (1 patent)

15. Jorge Cuevas González (1 patent)

4 patents: Sort by Forward Citations

1. 10864278 - Antibody-drug conjugates and immunotoxins (2020-12-15),

2. 10137202 - Antibody-drug conjugates and immunotoxins (2018-11-27),

3. 10004812 - Antibody-drug conjugates and immunotoxins (2018-06-26),

4. 9702879 - Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas (2017-07-11),

Company Overview

Oncomatryx Biopharma, S.l. is a biotechnology company focused on developing innovative therapies for cancer. With a strong emphasis on precision medicine, Oncomatryx is dedicated to creating targeted treatments that address the specific genetic and molecular characteristics of individual tumors. Their pipeline includes novel compounds and biologics designed to improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#5 in Derio

#516 in Spain

Derio, Spain

Oncomatryx Biopharma, S.l.

Forward Citations = 8

18 inventors:

Klaus Pfizenmaier (3 out of 21 patents)

Roland Kontermann (3 out of 25 patents)

Cristina Ferrer (3 out of 3 patents)

4. Myriam Fabre (3 out of 4 patents)

5. Laureano Simon (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oncomatryx Biopharma, S.l.. Retrieved from https://idiyas.com/company/oncomatryx-biopharma-s-l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]